Alternative Bio (ABio)

Develops precision medicines targeting protein synthesis for breakthrough cancer therapies.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Singapore

Initial Investment

2022
Develops precision medicines targeting protein synthesis for breakthrough cancer therapies.

Alternative Bio’s mission is to translate the discovery of novel protein synthesis regulatory nodes into first-in-class precision medicines to treat the most challenging cancers. The company’s vision is to establish itself as a global pioneer in this new research space as it advances breakthrough therapies to benefit cancer patients worldwide.